维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

13篇 您的检索式：作者名="Benbrook D"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	A novel or phanreceptor specific for a subset of thyroid hormone -responsiveelements and its interaction with the retinoid/thyroid hormonereceptor subfamily显示文摘	Apfel R Benbrook D Lemhardt E	1994	Mol Cell Biol1994，14，10：	1
	2	A new retinoic acid receptor identified from a hepatocellular carcinoma 显示文摘	BENBROOK D LERNHARDT E PFAHL M	1988	Nature1988，333，：	1
	3	A novel orphan receptor specific for a subset of thyroid hormone responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily显示文摘	APFEL R BENBROOK D LERNHARDT E	1994	Mol Cell Biol1994，14，10：	1
	4	A phase II trial of Thalidomide in patients with refractory endometrial cancer and correlation with angiogenesis biomarkers: a Gynecologic Oncology Group study 显示文摘	McMeekin DS Sill MW Benbrook D	2007	Gynecol Oncol2007，105，2：	1
	5	A novel orphan receptor specific for a subset of thyroid hormone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily 显示文摘	Apfel R Benbrook D Lernhardt E	1994	Mol Cell Biol1994，14，10：	1
	6	Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells显示文摘	Masamha C P Benbrook D M	2009	Cancer Res2009，69，16：	1
	7	A phase II trial of thalidomide in patients with refractory leiomyosarcoma of the uterus and correlation with biomarkers of angiogenesis: A gynecologic oncology group study 显示文摘	McMeekin D S Sill MW Benbrook D	2007	Gynecol Oncol2007，106，：	1
	8	The role of single nucleotide polymorphisms of the ERCC1 and MMS19 genes in predicting platinum-sensitivity,progression-free and overall survival in advanced epithelial ovarian cancer显示文摘	Moxley K M Benbrook D M Queimado L		0，，2：	1
	9	A novel or- phan receptor specific for a subset of thyroid hor- mone-responsive elements and its interaction with the retinoid/thyroid hormone receptor subfamily显示文摘	Apfel R Benbrook D Lemhardt E	1994	Mol Cell Biol1994，14，：	1
	10	A phaseⅡtrial of thalidomide in patients with refractory endometrial cancer and correlation with angiogenesis biomarkers:a Gynecologic Oncology Group study显示文摘	Mc Meekin DS Sill MW Benbrook D	2007	Gynecol Oncol2007，105，2：	1
	11	Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells显示文摘	Masamha C P Benbrook D M		0，，16：	1
	12	A phase Ⅱ trial of thalidomide in patients with refractory leiomyosarcoma of the uterus and correlation with biomarkers of angiogenesis:A gynecologic oncology group study 显示文摘	McMeekin DS Sill MW Benbrook D	2007	Gynecol Oncol2007，106，：	1
	13	A phase Ⅱ trial of thalidomide in patients with refractory endometrial cancer and correlation with angiogenesis biomarkers: A Gynecologic Oncology Group study 显示文摘	McMeekin DS Sill MW Benbrook D	2007	Gynecol Oncol2007，105，：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费